These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9327113)

  • 21. Adaptation to vection-induced symptoms of motion sickness.
    Stern RM; Hu SQ; Vasey MW; Koch KL
    Aviat Space Environ Med; 1989 Jun; 60(6):566-72. PubMed ID: 2751587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of manipulating expectations through placebo and nocebo administration on gastric tachyarrhythmia and motion-induced nausea.
    Levine ME; Stern RM; Koch KL
    Psychosom Med; 2006; 68(3):478-86. PubMed ID: 16738082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of expectations to motion sickness symptoms and gastric activity.
    Williamson MJ; Thomas MJ; Stern RM
    J Psychosom Res; 2004 Jun; 56(6):721-6. PubMed ID: 15193970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The retention of adaptation to motion sickness eliciting stimulation.
    Hu S; Stern RM
    Aviat Space Environ Med; 1999 Aug; 70(8):766-8. PubMed ID: 10447049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study.
    Marcus DA; Furman JM
    Med Sci Monit; 2006 Jan; 12(1):PI1-7. PubMed ID: 16369474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of antimotion sickness drug side effects on performance.
    Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
    Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in motion sickness history and susceptibility to optokinetic rotation-induced motion sickness.
    Park AH; Hu S
    Aviat Space Environ Med; 1999 Nov; 70(11):1077-80. PubMed ID: 10608604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of sixteen anti-motion sickness drugs under controlled laboratory conditions.
    Wood CD; Graybiel A
    Aerosp Med; 1968 Dec; 39(12):1341-4. PubMed ID: 4881887
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental research on antimotion sickness effects of Chinese medicine "pingandan" pills in cats.
    Pei JS; Tong BL; Chen KJ; Li CS; Zhang GX
    Chin Med J (Engl); 1992 Apr; 105(4):322-7. PubMed ID: 1618017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotation velocity change and motion sickness in an optokinetic drum.
    Bubka A; Bonato F; Urmey S; Mycewicz D
    Aviat Space Environ Med; 2006 Aug; 77(8):811-5. PubMed ID: 16909874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of spatial frequency of a vertically striped rotating drum on vection-induced motion sickness.
    Hu S; Davis MS; Klose AH; Zabinsky EM; Meux SP; Jacobsen HA; Westfall JM; Gruber MB
    Aviat Space Environ Med; 1997 Apr; 68(4):306-11. PubMed ID: 9096826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility.
    Uijtdehaage SH; Stern RM; Koch KL
    Aviat Space Environ Med; 1993 Jan; 64(1):1-8. PubMed ID: 8424733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motion-sickness medications for aircrew: impact on psychomotor performance.
    Paul MA; MacLellan M; Gray G
    Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
    Collins WE; Schroeder DJ; Elam GW
    Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired gastric slow waves induced by spatial disorientation and effect of domperidone.
    Kono T; Tokumaru O; Mizumoto C; Tatsuno J; Chen JD
    Am J Gastroenterol; 1999 May; 94(5):1224-9. PubMed ID: 10235198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optokinetic motion sickness: continuous head movements attenuate the visual induction of apparent self-rotation and symptoms of motion sickness.
    Lackner JR; Teixeira RA
    Aviat Space Environ Med; 1977 Mar; 48(3):248-53. PubMed ID: 857800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of severe motion sickness with antimotion sickness drug injections.
    Graybiel A; Lackner JR
    Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME; Royal JW; Shaw JE; Schmitt LG
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tachygastria and motion sickness.
    Stern RM; Koch KL; Leibowitz HW; Lindblad IM; Shupert CL; Stewart WR
    Aviat Space Environ Med; 1985 Nov; 56(11):1074-7. PubMed ID: 4074260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.